Ascendia Pharmaceutical Solutions Expanding Injectable Manufacturing Capabilities in 2024

Jan 31, 2024 12:00:00 AM

Ascendia Pharmaceutical Solutions Develops Novel Nanoemulsion IV Formulation for Clopidogrel that Received IND Approval

Jul 10, 2023 12:00:00 AM

How Lipid Nanoparticles Overcome Solubility Challenges for Oral and Injectable Formulations

Dec 8, 2022 12:00:00 AM